News

RMS
Sunday May 3th, 2022 A delegation from the Jordanian Association of Pharmacutical Manufactrures headed by Mr. Wasim Najmi and Dr. Hanan Sboul visitied the director general of the Royal Medical Services brigadier general Dr. Youssef Zarekat. The visit comes for the purposes of raising the level of communication with Royal Medical Services, strengthening areas of cooperation between the two parties. From his side, Mr. Najmi stressed that the Royal Medical Services presents constructive ideas that will contribute to a qualitative leap in the Jordanian medical sector in the near future.
king
JAPM participated in the National Economic Workshop’s second round represented by a number of JAPM members and the Secretary-General, Dr. Hanan Al-Sboul Source: The Jordan Times AMMAN- His Majesty King Abdullah on Saturday followed up on the second round of the National Economic Workshop, held at the Royal Hashemite Court under the theme “Advancing into the Future: Unleashing Potential to Modernise the Economy”. During a visit to the workshop, King Abdullah, accompanied by Prime Minister Bisher Al Khasawneh, spoke to participants in all sectors, and listened to briefings on ongoing discussions, according to a Royal Court statement. His Majesty stressed
elections
The General Assembly of JAPM held its regular annual meeting at 3:30 PM on Thursday, 03/03/2022 at JAPM office in the presence of representatives of (13) Pharmaceutical Manufacturers company¸ representatives of Al-Sanad Law Firm - Legal Advisers, and Arab Professional Group; auditors of JAPM. The general assembly unanimously elected Mr. Wassim Al-Najami as Chairman of JAPM, and a new Executive committee was elected; as below: Mr. Tareq Darwazeh | Vice Chairman - Hikma Pharmaceuticals Dr. Abdulmonem Alali | Secretary - Pharma International Co (PIC) Dr. Fadi Al-Atrash | Treasury - Amman Pharmaceutical Industries Co (API) Dr. Maher Al Kurdi |
COVID19
Prime Minister Bishr Al-Khasawneh announced that the government will soon make the announcement of gradually lifting all measures related to combating the spread of COVID-19 within weeks.
IGBA
IGBA, the International Generic and Biosimilar Medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announced today that Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), is taking over the position of IGBA Chair for 2021 from Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers. “2020 was an unprecedented year in many ways. Tremendous engagement and commitment by our member associations and their member companies were required to face up to the numerous challenges never encountered before to ensure that patients worldwide get the treatments they need”, commented the outgoing IGBA Chair Hanan
country status
Dr. Hanan Sboul participated in the meeting of country status report 2020 discussion, which discussed the health sector status during the Corona pandemic, the meeting was held Dec. 28th 2020, the Minister of Health Natheer Obeidat said Monday that a proposal is currently under consideration for the introduction of universal healthcare insurance that leads to setting up a unified referral entity that involves multiple stakeholders. This type of insurance will be under one umbrella and one fund managed by the Ministry of Health with the participation of many bodies, such as the Social Security Corporation, Obeidat told a Zoom-powered meeting
biosimilar week
IGBA will be launching tomorrow the Global Biosimilars Week November which will be 16 - 20 Nov. 2020 IGBA member companies are the pioneers and global leaders in the development and marketing of biosimilar medicines. Global Biosimilars Week is a time to engage in a globally aligned educational initiative to raise awareness of biosimilar medicines. Through daily themes, we encourage you to share resources about the value of biosimilars: biosimilar basics, regulation, benefits, clinical use and market adoption as well as future opportunities for patients, healthcare professionals and healthcare system. Follow hashtag #GlobalBiosimilarsWeek on social media Message of the IGBA
COVID19
Jordan has recorded 60 deaths and 7,933 new coronavirus cases Wednesday, bringing the total number of cases since the beginning of the coronavirus crisis to 163,926. The number of COVID-19 deaths in Jordan now totals 1,969. The cases are: 2,412 in Amman 998 in Irbid, including 230 in Ramtha 522 in Zarqa 347 in Karak 144 in Ma'an, including 70 in Petra 65 in Tafilah 1,893 in Aqaba 708 in Jerash 379 in Balqa 291 in Madaba 127 in Mafraq 47 in Ajloun A total of 248 cases have been admitted to the hospitals, and 214 have been discharged upon
HU
تعزيزًا للتعاون المشترك العلمي والتطبيقي وتبادل الخبرات والتدريب في مجال الصيدلة، وُقع المركز الريادي للأبحاث الأكاديمية التطبيقية في إدارة الرعاية العلاجية وخدمة المرضى في الجامعة الهاشمية والاتحاد الأردني لمنتجي الادوية مذكرة تفاهم مشتركة بين الجانبين، وقعها عن الاتحاد الدكتور ماهر محمد الكردي رئيس الاتحاد وعن الجامعة الأستاذ الدكتور فواز عبد الحق الزبون رئيس الجامعة، بحضور كل من أمين عام الاتحاد الدكتورة حنان السبول والدكتور مهند عودة مدير المركز الريادي. تهدف المذكرة إلى تبادل الخبرات في الشؤون العلمية والتطبيقية والرقابية والتعاون في مجالات البحث العلمي التطبيقي وتأهيل طلبة كليات الصيدلة لتزويدهم بالمهارات اللازمة حسب متطلبات العمل في مجال الصناعة الدوائية وتقديم
COVID19
The Minister of Labour announced the new amendments to the procedures that must be taken in the private sector to prevent and limit the spread of the Corona virus and transmit infection during the second wave of COVID-19, in the workplace to deal with epidemics and to protect workers and employers in the work environment To read the procedure please visit the link: http://www.mol.gov.jo/Default/Ar